Vivos Therapeutics
VVOS
VVOS
30 hedge funds and large institutions have $1.71M invested in Vivos Therapeutics in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Holders
30
Holding in Top 10
–
Calls
$14K
Puts
–
Top Buyers
| 1 | +$1.1M | |
| 2 | +$31.7K | |
| 3 | +$31K | |
| 4 |
Renaissance Technologies
New York
|
+$24.6K |
| 5 |
VF
Virtu Financial
New York
|
+$16K |
Top Sellers
| 1 | -$14.2K | |
| 2 | -$10.5K | |
| 3 | -$7.53K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$4.91K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.32K |